Polaris Ventures

Visit Our Blog

This content requires the Flash Plugin.

Founded in 1996, Polaris has backed and played a lead role in developing some of the most successful information technology and life sciences companies in the United States and Europe.

Diversification - across and within industries, and in stage - is the cornerstone of Polaris' investment strategy.

We have built an exceptional team of venture capitalists and technology executives with a broad range of investment and operating experience, the highest business standards, and a commitment to success.

Helping build first-rate management teams is a key commitment we make to the companies we back. Our on-staff team has recruited to our portfolio companies more than 50 executives for a wide range of positions without the use of an outside recruiter, from CEO to the director level.

Polaris has backed many companies that have become stars in their fields.

Avila Therapeutics Story Shows Early, Series-A Life Sciences Investing Pays Off

Full Story

Improving the virtual biotech model, PVP partners with Janssen Research and Development, LLC @dogpatchlabs

Full Story

Cerulean Pharma & Polaris Venture Partners CNBC Interview

CNBC interviews Oliver Fetzer of Cerulean and Terry McGuire of Polaris.

Watch It Here



1/15/2012 Biotechs strike partnerships to spread their costs, risks

12/28/2011 Acceleron Pharma Secures $30 Million Private Financing 12/22/2011 DigiCert Named One of Utahs Best Companies to Work For 12/22/2011 Quantcast raises $8 million



1/26/2012 Celgene Buys Avila for $350M, Gaining Promising �Covalent� Drugs

1/24/2012 This could be the year of nanotech-enabled medicines 1/20/2012 Start-ups saw big rise in funding during �11 - Biotech sector led way in region 1/1/2012 Funding Solutions for Life Science Startups